 | • レポートコード：QFJ1-5079 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、動脈瘤治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医学、外科手術、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・動脈瘤治療の市場動向 ・企業の競争状況、市場シェア ・動脈瘤治療の種類別市場規模と予測2016-2027（医学、外科手術、その他） ・動脈瘤治療の用途別市場規模と予測2016-2027（病院、診療所、その他） ・動脈瘤治療の北米市場規模2016-2027（アメリカ、カナダ） ・動脈瘤治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・動脈瘤治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・動脈瘤治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・動脈瘤治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GE Healthcare、Endologix、JOTEC、Lombard Medical、Terumo Medical、Cardinal Health、Cook Medical Devices、Medtronic、Lifetech Scientific、Gore Medical、Pfizer） ・結論 |
An aneurysm is the enlargement of an artery caused by weakness in the arterial wall.
Market Analysis and Insights: Global Aneurysm Therapeutics Market
The global Aneurysm Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Aneurysm Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Aneurysm Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Aneurysm Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Aneurysm Therapeutics market.
Global Aneurysm Therapeutics Scope and Market Size
Aneurysm Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Aneurysm Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Medicine
Surgery
Other
Segment by Application
Hospital
Clinic
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
GE Healthcare
Endologix
JOTEC
Lombard Medical
Terumo Medical
Cardinal Health
Cook Medical Devices
Medtronic
Lifetech Scientific
Gore Medical
Pfizer
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Aneurysm Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medicine
1.2.3 Surgery
1.2.4 Other
1.3 Market by Application
1.3.1 Global Aneurysm Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Aneurysm Therapeutics Market Perspective (2016-2027)
2.2 Aneurysm Therapeutics Growth Trends by Regions
2.2.1 Aneurysm Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Aneurysm Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Aneurysm Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Aneurysm Therapeutics Industry Dynamic
2.3.1 Aneurysm Therapeutics Market Trends
2.3.2 Aneurysm Therapeutics Market Drivers
2.3.3 Aneurysm Therapeutics Market Challenges
2.3.4 Aneurysm Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Aneurysm Therapeutics Players by Revenue
3.1.1 Global Top Aneurysm Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Aneurysm Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Aneurysm Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Aneurysm Therapeutics Revenue
3.4 Global Aneurysm Therapeutics Market Concentration Ratio
3.4.1 Global Aneurysm Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Aneurysm Therapeutics Revenue in 2020
3.5 Aneurysm Therapeutics Key Players Head office and Area Served
3.6 Key Players Aneurysm Therapeutics Product Solution and Service
3.7 Date of Enter into Aneurysm Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Aneurysm Therapeutics Breakdown Data by Type
4.1 Global Aneurysm Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Aneurysm Therapeutics Forecasted Market Size by Type (2022-2027)
5 Aneurysm Therapeutics Breakdown Data by Application
5.1 Global Aneurysm Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Aneurysm Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Aneurysm Therapeutics Market Size (2016-2027)
6.2 North America Aneurysm Therapeutics Market Size by Type
6.2.1 North America Aneurysm Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Aneurysm Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Aneurysm Therapeutics Market Size by Type (2016-2027)
6.3 North America Aneurysm Therapeutics Market Size by Application
6.3.1 North America Aneurysm Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Aneurysm Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Aneurysm Therapeutics Market Size by Application (2016-2027)
6.4 North America Aneurysm Therapeutics Market Size by Country
6.4.1 North America Aneurysm Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Aneurysm Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Aneurysm Therapeutics Market Size (2016-2027)
7.2 Europe Aneurysm Therapeutics Market Size by Type
7.2.1 Europe Aneurysm Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Aneurysm Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Aneurysm Therapeutics Market Size by Type (2016-2027)
7.3 Europe Aneurysm Therapeutics Market Size by Application
7.3.1 Europe Aneurysm Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Aneurysm Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Aneurysm Therapeutics Market Size by Application (2016-2027)
7.4 Europe Aneurysm Therapeutics Market Size by Country
7.4.1 Europe Aneurysm Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Aneurysm Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Aneurysm Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Aneurysm Therapeutics Market Size by Type
8.2.1 Asia-Pacific Aneurysm Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Aneurysm Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Aneurysm Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Aneurysm Therapeutics Market Size by Application
8.3.1 Asia-Pacific Aneurysm Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Aneurysm Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Aneurysm Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Aneurysm Therapeutics Market Size by Region
8.4.1 Asia-Pacific Aneurysm Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Aneurysm Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Aneurysm Therapeutics Market Size (2016-2027)
9.2 Latin America Aneurysm Therapeutics Market Size by Type
9.2.1 Latin America Aneurysm Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Aneurysm Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Aneurysm Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Aneurysm Therapeutics Market Size by Application
9.3.1 Latin America Aneurysm Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Aneurysm Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Aneurysm Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Aneurysm Therapeutics Market Size by Country
9.4.1 Latin America Aneurysm Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Aneurysm Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Aneurysm Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Aneurysm Therapeutics Market Size by Type
10.2.1 Middle East & Africa Aneurysm Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Aneurysm Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Aneurysm Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Aneurysm Therapeutics Market Size by Application
10.3.1 Middle East & Africa Aneurysm Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Aneurysm Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Aneurysm Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Aneurysm Therapeutics Market Size by Country
10.4.1 Middle East & Africa Aneurysm Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Aneurysm Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Details
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Aneurysm Therapeutics Introduction
11.1.4 GE Healthcare Revenue in Aneurysm Therapeutics Business (2016-2021)
11.1.5 GE Healthcare Recent Development
11.2 Endologix
11.2.1 Endologix Company Details
11.2.2 Endologix Business Overview
11.2.3 Endologix Aneurysm Therapeutics Introduction
11.2.4 Endologix Revenue in Aneurysm Therapeutics Business (2016-2021)
11.2.5 Endologix Recent Development
11.3 JOTEC
11.3.1 JOTEC Company Details
11.3.2 JOTEC Business Overview
11.3.3 JOTEC Aneurysm Therapeutics Introduction
11.3.4 JOTEC Revenue in Aneurysm Therapeutics Business (2016-2021)
11.3.5 JOTEC Recent Development
11.4 Lombard Medical
11.4.1 Lombard Medical Company Details
11.4.2 Lombard Medical Business Overview
11.4.3 Lombard Medical Aneurysm Therapeutics Introduction
11.4.4 Lombard Medical Revenue in Aneurysm Therapeutics Business (2016-2021)
11.4.5 Lombard Medical Recent Development
11.5 Terumo Medical
11.5.1 Terumo Medical Company Details
11.5.2 Terumo Medical Business Overview
11.5.3 Terumo Medical Aneurysm Therapeutics Introduction
11.5.4 Terumo Medical Revenue in Aneurysm Therapeutics Business (2016-2021)
11.5.5 Terumo Medical Recent Development
11.6 Cardinal Health
11.6.1 Cardinal Health Company Details
11.6.2 Cardinal Health Business Overview
11.6.3 Cardinal Health Aneurysm Therapeutics Introduction
11.6.4 Cardinal Health Revenue in Aneurysm Therapeutics Business (2016-2021)
11.6.5 Cardinal Health Recent Development
11.7 Cook Medical Devices
11.7.1 Cook Medical Devices Company Details
11.7.2 Cook Medical Devices Business Overview
11.7.3 Cook Medical Devices Aneurysm Therapeutics Introduction
11.7.4 Cook Medical Devices Revenue in Aneurysm Therapeutics Business (2016-2021)
11.7.5 Cook Medical Devices Recent Development
11.8 Medtronic
11.8.1 Medtronic Company Details
11.8.2 Medtronic Business Overview
11.8.3 Medtronic Aneurysm Therapeutics Introduction
11.8.4 Medtronic Revenue in Aneurysm Therapeutics Business (2016-2021)
11.8.5 Medtronic Recent Development
11.9 Lifetech Scientific
11.9.1 Lifetech Scientific Company Details
11.9.2 Lifetech Scientific Business Overview
11.9.3 Lifetech Scientific Aneurysm Therapeutics Introduction
11.9.4 Lifetech Scientific Revenue in Aneurysm Therapeutics Business (2016-2021)
11.9.5 Lifetech Scientific Recent Development
11.10 Gore Medical
11.10.1 Gore Medical Company Details
11.10.2 Gore Medical Business Overview
11.10.3 Gore Medical Aneurysm Therapeutics Introduction
11.10.4 Gore Medical Revenue in Aneurysm Therapeutics Business (2016-2021)
11.10.5 Gore Medical Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Aneurysm Therapeutics Introduction
11.11.4 Pfizer Revenue in Aneurysm Therapeutics Business (2016-2021)
11.11.5 Pfizer Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Aneurysm Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medicine
Table 3. Key Players of Surgery
Table 4. Key Players of Other
Table 5. Global Aneurysm Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Aneurysm Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Aneurysm Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Aneurysm Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Aneurysm Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Aneurysm Therapeutics Market Share by Regions (2022-2027)
Table 11. Aneurysm Therapeutics Market Trends
Table 12. Aneurysm Therapeutics Market Drivers
Table 13. Aneurysm Therapeutics Market Challenges
Table 14. Aneurysm Therapeutics Market Restraints
Table 15. Global Aneurysm Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Aneurysm Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Aneurysm Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Aneurysm Therapeutics as of 2020)
Table 18. Ranking of Global Top Aneurysm Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Aneurysm Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Aneurysm Therapeutics Product Solution and Service
Table 22. Date of Enter into Aneurysm Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Aneurysm Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Aneurysm Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Aneurysm Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Aneurysm Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Aneurysm Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Aneurysm Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Aneurysm Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Aneurysm Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Aneurysm Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Aneurysm Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Aneurysm Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Aneurysm Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Aneurysm Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Aneurysm Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Aneurysm Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Aneurysm Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Aneurysm Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Aneurysm Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Aneurysm Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Aneurysm Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Aneurysm Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Aneurysm Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Aneurysm Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Aneurysm Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Aneurysm Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Aneurysm Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Aneurysm Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Aneurysm Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Aneurysm Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Aneurysm Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Aneurysm Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Aneurysm Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Aneurysm Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Aneurysm Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Aneurysm Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Aneurysm Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Aneurysm Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Aneurysm Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. GE Healthcare Company Details
Table 63. GE Healthcare Business Overview
Table 64. GE Healthcare Aneurysm Therapeutics Product
Table 65. GE Healthcare Revenue in Aneurysm Therapeutics Business (2016-2021) & (US$ Million)
Table 66. GE Healthcare Recent Development
Table 67. Endologix Company Details
Table 68. Endologix Business Overview
Table 69. Endologix Aneurysm Therapeutics Product
Table 70. Endologix Revenue in Aneurysm Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Endologix Recent Development
Table 72. JOTEC Company Details
Table 73. JOTEC Business Overview
Table 74. JOTEC Aneurysm Therapeutics Product
Table 75. JOTEC Revenue in Aneurysm Therapeutics Business (2016-2021) & (US$ Million)
Table 76. JOTEC Recent Development
Table 77. Lombard Medical Company Details
Table 78. Lombard Medical Business Overview
Table 79. Lombard Medical Aneurysm Therapeutics Product
Table 80. Lombard Medical Revenue in Aneurysm Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Lombard Medical Recent Development
Table 82. Terumo Medical Company Details
Table 83. Terumo Medical Business Overview
Table 84. Terumo Medical Aneurysm Therapeutics Product
Table 85. Terumo Medical Revenue in Aneurysm Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Terumo Medical Recent Development
Table 87. Cardinal Health Company Details
Table 88. Cardinal Health Business Overview
Table 89. Cardinal Health Aneurysm Therapeutics Product
Table 90. Cardinal Health Revenue in Aneurysm Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Cardinal Health Recent Development
Table 92. Cook Medical Devices Company Details
Table 93. Cook Medical Devices Business Overview
Table 94. Cook Medical Devices Aneurysm Therapeutics Product
Table 95. Cook Medical Devices Revenue in Aneurysm Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Cook Medical Devices Recent Development
Table 97. Medtronic Company Details
Table 98. Medtronic Business Overview
Table 99. Medtronic Revenue in Aneurysm Therapeutics Business (2016-2021) & (US$ Million)
Table 100. Medtronic Recent Development
Table 101. Lifetech Scientific Company Details
Table 102. Lifetech Scientific Business Overview
Table 103. Lifetech Scientific Aneurysm Therapeutics Product
Table 104. Lifetech Scientific Revenue in Aneurysm Therapeutics Business (2016-2021) & (US$ Million)
Table 105. Lifetech Scientific Recent Development
Table 106. Gore Medical Company Details
Table 107. Gore Medical Business Overview
Table 108. Gore Medical Aneurysm Therapeutics Product
Table 109. Gore Medical Revenue in Aneurysm Therapeutics Business (2016-2021) & (US$ Million)
Table 110. Gore Medical Recent Development
Table 111. Pfizer Company Details
Table 112. Pfizer Business Overview
Table 113. Pfizer Aneurysm Therapeutics Product
Table 114. Pfizer Revenue in Aneurysm Therapeutics Business (2016-2021) & (US$ Million)
Table 115. Pfizer Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Aneurysm Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Medicine Features
Figure 3. Surgery Features
Figure 4. Other Features
Figure 5. Global Aneurysm Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Other Case Studies
Figure 9. Aneurysm Therapeutics Report Years Considered
Figure 10. Global Aneurysm Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Aneurysm Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Aneurysm Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Aneurysm Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Aneurysm Therapeutics Market Share by Players in 2020
Figure 15. Global Top Aneurysm Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Aneurysm Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Aneurysm Therapeutics Revenue in 2020
Figure 17. Global Aneurysm Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Aneurysm Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Aneurysm Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Aneurysm Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Aneurysm Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Aneurysm Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Aneurysm Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Aneurysm Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Aneurysm Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Aneurysm Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Aneurysm Therapeutics Market Share by Region (2016-2027)
Figure 39. China Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Aneurysm Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Aneurysm Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Aneurysm Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Aneurysm Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Aneurysm Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Aneurysm Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Aneurysm Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. GE Healthcare Revenue Growth Rate in Aneurysm Therapeutics Business (2016-2021)
Figure 59. Endologix Revenue Growth Rate in Aneurysm Therapeutics Business (2016-2021)
Figure 60. JOTEC Revenue Growth Rate in Aneurysm Therapeutics Business (2016-2021)
Figure 61. Lombard Medical Revenue Growth Rate in Aneurysm Therapeutics Business (2016-2021)
Figure 62. Terumo Medical Revenue Growth Rate in Aneurysm Therapeutics Business (2016-2021)
Figure 63. Cardinal Health Revenue Growth Rate in Aneurysm Therapeutics Business (2016-2021)
Figure 64. Cook Medical Devices Revenue Growth Rate in Aneurysm Therapeutics Business (2016-2021)
Figure 65. Medtronic Revenue Growth Rate in Aneurysm Therapeutics Business (2016-2021)
Figure 66. Lifetech Scientific Revenue Growth Rate in Aneurysm Therapeutics Business (2016-2021)
Figure 67. Gore Medical Revenue Growth Rate in Aneurysm Therapeutics Business (2016-2021)
Figure 68. Pfizer Revenue Growth Rate in Aneurysm Therapeutics Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
世界の大動脈瘤市場規模・現状・予測（2021年-2027年） An aortic aneurysm is an enlargement (dilatation) of the aortato greater than 1.5 times normal size. Market Analysis and Insights: Global Aortic Aneurysm Market The global Aortic Aneurysm market size is projected to reach US$ 3215.1 million by 2027, from US$ 2250.9 million in 2020, at a CAGR of 4.8%…- 世界の脳動脈瘤治療市場規模・現状・予測（2021年-2027年） Intracranial aneurysm, also known as brain or cerebral aneurysm, is a bulging, weakened area in the wall of an artery in the brain. It results in an abnormal ballooning, widening, or bleb. An intracranial aneurysm majorly occurs in an artery located in the front part of the brain, which supplies oxy…
- 世界の抗菌治療薬市場規模・現状・予測（2021年-2027年） An antimicrobial is an agent that kills microorganisms or stops their growth. The increasing prevalence of deadly diseases such as HIV and HPV has created the need for high-quality diagnostics which will enable early diagnosis of the infection. Technological advancements in the healthcare industry h…
- 世界のCOPD治療薬市場規模・現状・予測（2021年-2027年） Chronic Obstructive Pulmonary Disease (COPD) is a progressive disorder associated with chronic inflammation of the airways and lungs. Persistent breathing difficulties and repeated exacerbations of COPD symptoms make the disease one of the leading causes of morbidity, and the fifth-leading cause of …
- 世界のアトピー性皮膚炎治療薬市場規模・現状・予測（2021年-2027年） Atopic dermatitis (AD), also called atopic eczema, is a chronic, pruritic, inflammatory skin disease arising from a complex interrelationship of environmental, immunologic, genetic, and pharmacologic factors, with a characteristic phenotype and typically distributed skin lesions. Market Analysis and…